Japan Animal Referral Medical Center Co., Ltd. (TYO:6039)
Japan
· Delayed Price · Currency is JPY 2,610.00
-78.00 (-2.90%)
Apr 24, 2025, 3:30 PM JST
TYO:6039 Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Revenue | 5,097 | 4,270 | 3,872 | 2,979 | 2,847 | 2,734 | Upgrade
|
| Revenue Growth (YoY) | 25.16% | 10.28% | 29.98% | 4.64% | 4.13% | 6.67% | Upgrade
|
| Cost of Revenue | 3,274 | 2,806 | 2,430 | 1,873 | 1,853 | 1,726 | Upgrade
|
| Gross Profit | 1,823 | 1,464 | 1,442 | 1,106 | 994 | 1,008 | Upgrade
|
| Selling, General & Admin | 982.05 | 868 | 758 | 576 | 513 | 499 | Upgrade
|
| Other Operating Expenses | 69 | 69 | 68 | 59 | 59 | 59 | Upgrade
|
| Operating Expenses | 1,081 | 967 | 862 | 666 | 589 | 577 | Upgrade
|
| Operating Income | 741.62 | 497 | 580 | 440 | 405 | 431 | Upgrade
|
| Interest Expense | -23.45 | -19 | -17 | -13 | -13 | -15 | Upgrade
|
| Other Non Operating Income (Expenses) | 28 | 31 | -13 | 11 | 23 | 34 | Upgrade
|
| EBT Excluding Unusual Items | 746.18 | 509 | 550 | 438 | 415 | 450 | Upgrade
|
| Gain (Loss) on Sale of Assets | -19.51 | -18 | -17 | -1 | -4 | - | Upgrade
|
| Asset Writedown | 18.36 | - | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | -15 | - | - | Upgrade
|
| Pretax Income | 745.03 | 491 | 533 | 422 | 411 | 450 | Upgrade
|
| Income Tax Expense | 219.43 | 154 | 153 | 136 | 126 | 138 | Upgrade
|
| Net Income | 525.6 | 337 | 380 | 286 | 285 | 312 | Upgrade
|
| Net Income to Common | 525.6 | 337 | 380 | 286 | 285 | 312 | Upgrade
|
| Net Income Growth | 63.74% | -11.32% | 32.87% | 0.35% | -8.65% | 6.12% | Upgrade
|
| Shares Outstanding (Basic) | 3 | 3 | 2 | 2 | 2 | 2 | Upgrade
|
| Shares Outstanding (Diluted) | 3 | 3 | 2 | 2 | 2 | 3 | Upgrade
|
| Shares Change (YoY) | -7.27% | 11.92% | 2.18% | -0.26% | -3.17% | -0.11% | Upgrade
|
| EPS (Basic) | 200.39 | 122.93 | 156.06 | 120.56 | 120.65 | 128.46 | Upgrade
|
| EPS (Diluted) | 199.57 | 121.26 | 153.20 | 118.00 | 116.98 | 124.24 | Upgrade
|
| EPS Growth | 73.08% | -20.85% | 29.83% | 0.87% | -5.84% | 6.18% | Upgrade
|
| Free Cash Flow | - | -141 | 82 | -44 | 440 | 468 | Upgrade
|
| Free Cash Flow Per Share | - | -50.71 | 33.00 | -18.09 | 180.48 | 185.88 | Upgrade
|
| Dividend Per Share | 20.000 | 20.000 | - | - | - | - | Upgrade
|
| Gross Margin | - | 34.29% | 37.24% | 37.13% | 34.91% | 36.87% | Upgrade
|
| Operating Margin | 14.55% | 11.64% | 14.98% | 14.77% | 14.23% | 15.76% | Upgrade
|
| Profit Margin | 10.31% | 7.89% | 9.81% | 9.60% | 10.01% | 11.41% | Upgrade
|
| Free Cash Flow Margin | - | -3.30% | 2.12% | -1.48% | 15.46% | 17.12% | Upgrade
|
| EBITDA | 1,245 | 961 | 991 | 681 | 625 | 648 | Upgrade
|
| EBITDA Margin | - | 22.51% | 25.59% | 22.86% | 21.95% | 23.70% | Upgrade
|
| D&A For EBITDA | 503.75 | 464 | 411 | 241 | 220 | 217 | Upgrade
|
| EBIT | 741.62 | 497 | 580 | 440 | 405 | 431 | Upgrade
|
| EBIT Margin | - | 11.64% | 14.98% | 14.77% | 14.23% | 15.76% | Upgrade
|
| Effective Tax Rate | - | 31.36% | 28.71% | 32.23% | 30.66% | 30.67% | Upgrade
|
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.